Dr Reddys Laboratories (RDY) Profit After Tax Growth (3y) (2012 - 2023)
Dr Reddys Laboratories (RDY) Profit After Tax Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | -87.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 17.80% |
| Mar 31, 2023 | 29.61% |
| Sep 30, 2022 | -98.69% |
| Jun 30, 2021 | 26.63% |
| Mar 31, 2021 | 6.92% |
| Sep 30, 2020 | -51.42% |
| Sep 30, 2019 | -7.53% |
| Mar 31, 2019 | 7.95% |
| Dec 31, 2018 | -0.52% |
| Sep 30, 2018 | -6.99% |
| Jun 30, 2018 | -15.66% |
| Dec 31, 2017 | -17.02% |
| Sep 30, 2017 | -18.53% |
| Dec 31, 2016 | -38.59% |
| Sep 30, 2016 | -22.11% |
| Mar 31, 2016 | 15.09% |
| Dec 31, 2015 | -15.21% |
| Sep 30, 2015 | -2.20% |
| Jun 30, 2015 | -70.00% |
| Dec 31, 2014 | -71.78% |